Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04737980 · ClinicalTrials.gov registry record · Phase 4

Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair

A Phase 4 study of Shoulder Pain and Rotator Cuff Tears, sponsored by Hospital for Special Surgery Florida.

Completed
Registry status
Phase 4
Development phase
92
Enrollment target
1
Study location

NCT04737980: Completed Phase 4 study of Shoulder Pain and Rotator Cuff Tears, sponsored by Hospital for Special Surgery Florida.

NCT04737980 is a Phase 4 study of Shoulder Pain and Rotator Cuff Tears that has completed, run by Hospital for Special Surgery Florida. The registered enrollment target is 92 participants, roughly in line with the 98-participant average among 27 other Shoulder Pain trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04737980, a Phase 4 study of Shoulder Pain and Rotator Cuff Tears, has completed, sponsored by Hospital for Special Surgery Florida.

COMPLETED
Registry status
Phase 4
Development phase
92 participants
Enrollment target
1
Study location

Study Summary

This study is a comparison of analgesia effect from peripheral nerve blockade (PNB) with liposomal bupivacaine combined with bupivacaine compared to PNB with ropivacaine combined with dexamethasone for arthroscopic rotator cuff repair.

Primary Outcome

Daily opioid consumption reported as OMED

Interventions

  • DRUG Dexamethasone
  • DRUG Ropivacaine 0.5% Injectable Solution
  • DRUG Liposomal bupivacaine
  • DRUG Bupivacaine Hcl 0.5% Inj

Study Locations (1)

Florida

  • HSS Florida - West Palm Beach

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2019-07-18
Est. Completion 2020-03-18
Phase Phase 4

What the finished NCT04737980 record still lists

NCT04737980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, roughly in line with the 98-participant average among 27 other Shoulder Pain trials with a reported enrollment target.

The record links to 2 conditions, with Shoulder Pain appearing as the primary indexed condition, and to 4 interventions - of which Dexamethasone is the first listed.

NCT04737980 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT04737980 about?

NCT04737980 is a clinical study titled "Liposomal Bupivacaine Plus Bupivacaine Peripheral Nerve Blockade Versus Ropivacaine Plus Dexamethasone Peripheral Nerve Blockade for Arthroscopic Rotator Cuff Repair". This study is a comparison of analgesia effect from peripheral nerve blockade (PNB) with liposomal bupivacaine combined with bupivacaine compared to PNB with ropivacaine combined with dexamethasone for arthroscopic rotator cuff repair.

What is the current status of trial NCT04737980?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 92 participants. The study started on 2019-07-18. Estimated completion is 2020-03-18.

What conditions does trial NCT04737980 study?

This clinical trial studies the following conditions: Shoulder Pain, Rotator Cuff Tears.

What interventions are being tested in trial NCT04737980?

The interventions under investigation include: Dexamethasone (DRUG), Ropivacaine 0.5% Injectable Solution (DRUG), Liposomal bupivacaine (DRUG), Bupivacaine Hcl 0.5% Inj (DRUG).

Who is sponsoring clinical trial NCT04737980?

This trial is sponsored by Hospital for Special Surgery Florida, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04737980 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Shoulder Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04737980's enrollment target sits among peer trials

92 9th of 27 higher than 18 of 27 other Shoulder Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Shoulder Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03184545 · 92 participants · Phase 3

    Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome

  • NCT04172532 · 92 participants · Phase 1

    Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • NCT04508088 · 92 participants

    Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

  • NCT04840602 · 92 participants · Phase 2

    Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04737980, the US trial registry maintained by the National Library of Medicine. NCT04737980 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.